Suppr超能文献

慢性阻塞性肺疾病患者的严重急性加重和死亡率

Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

作者信息

Soler-Cataluña J J, Martínez-García M A, Román Sánchez P, Salcedo E, Navarro M, Ochando R

机构信息

Unidad de Neumología, Servicio de Medicina Interna, Hospital General de Requena, Paraje Casablanca s/n 46340, Requena (Valencia), Spain.

出版信息

Thorax. 2005 Nov;60(11):925-31. doi: 10.1136/thx.2005.040527. Epub 2005 Jul 29.

Abstract

BACKGROUND

Patients with chronic obstructive pulmonary disease (COPD) often present with severe acute exacerbations requiring hospital treatment. However, little is known about the prognostic consequences of these exacerbations. A study was undertaken to investigate whether severe acute exacerbations of COPD exert a direct effect on mortality.

METHODS

Multivariate techniques were used to analyse the prognostic influence of acute exacerbations of COPD treated in hospital (visits to the emergency service and admissions), patient age, smoking, body mass index, co-morbidity, long term oxygen therapy, forced spirometric parameters, and arterial blood gas tensions in a prospective cohort of 304 men with COPD followed up for 5 years. The mean (SD) age of the patients was 71 (9) years and forced expiratory volume in 1 second was 46 (17)%.

RESULTS

Only older age (hazard ratio (HR) 5.28, 95% CI 1.75 to 15.93), arterial carbon dioxide tension (HR 1.07, 95% CI 1.02 to 1.12), and acute exacerbations of COPD were found to be independent indicators of a poor prognosis. The patients with the greatest mortality risk were those with three or more acute COPD exacerbations (HR 4.13, 95% CI 1.80 to 9.41).

CONCLUSIONS

This study shows for the first time that severe acute exacerbations of COPD have an independent negative impact on patient prognosis. Mortality increases with the frequency of severe exacerbations, particularly if these require admission to hospital.

摘要

背景

慢性阻塞性肺疾病(COPD)患者常出现需要住院治疗的严重急性加重。然而,对于这些加重的预后后果知之甚少。开展了一项研究以调查COPD严重急性加重是否对死亡率有直接影响。

方法

采用多变量技术分析在医院治疗的COPD急性加重(急诊就诊和住院)、患者年龄、吸烟、体重指数、合并症、长期氧疗、用力肺活量参数以及动脉血气张力对304名COPD男性前瞻性队列的预后影响,随访5年。患者的平均(标准差)年龄为71(9)岁,1秒用力呼气量为46(17)%。

结果

仅发现年龄较大(风险比(HR)5.28,95%置信区间1.75至15.93)、动脉血二氧化碳张力(HR 1.07,95%置信区间1.02至1.12)以及COPD急性加重是预后不良的独立指标。死亡风险最高的患者是那些发生三次或更多次COPD急性加重的患者(HR 4.13,95%置信区间1.80至9.41)。

结论

本研究首次表明,COPD严重急性加重对患者预后有独立的负面影响。死亡率随严重加重的频率增加,特别是如果这些加重需要住院治疗。

相似文献

1
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.
Thorax. 2005 Nov;60(11):925-31. doi: 10.1136/thx.2005.040527. Epub 2005 Jul 29.
2
Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
Respir Med. 2009 May;103(5):692-9. doi: 10.1016/j.rmed.2008.12.005. Epub 2009 Jan 7.
3
Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
Respir Med. 2008 Apr;102(4):613-9. doi: 10.1016/j.rmed.2007.11.004. Epub 2007 Dec 20.
4
Recent improvement in long-term survival after a COPD hospitalisation.
Thorax. 2010 Apr;65(4):298-302. doi: 10.1136/thx.2009.124818.
6
In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease.
Arch Intern Med. 2003 May 26;163(10):1180-6. doi: 10.1001/archinte.163.10.1180.
8
Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD).
Respir Med. 2007 Sep;101(9):1954-60. doi: 10.1016/j.rmed.2007.04.009. Epub 2007 May 25.
10
Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.
Int J Clin Pract. 2008 Apr;62(4):585-92. doi: 10.1111/j.1742-1241.2008.01707.x. Epub 2008 Feb 7.

引用本文的文献

6
Characteristics and actions in high-risk COPD in unstable patients: The EPOCONSUL audit.
PLoS One. 2025 Jul 18;20(7):e0327775. doi: 10.1371/journal.pone.0327775. eCollection 2025.
7
Inflammatory cells and remodeling in bronchial biopsies from COPD patients and controls.
PLoS One. 2025 Jun 17;20(6):e0326267. doi: 10.1371/journal.pone.0326267. eCollection 2025.

本文引用的文献

1
Erlotinib in lung cancer - molecular and clinical predictors of outcome.
N Engl J Med. 2005 Jul 14;353(2):133-44. doi: 10.1056/NEJMoa050736.
2
Erlotinib in previously treated non-small-cell lung cancer.
N Engl J Med. 2005 Jul 14;353(2):123-32. doi: 10.1056/NEJMoa050753.
3
The TORCH (towards a revolution in COPD health) survival study protocol.
Eur Respir J. 2004 Aug;24(2):206-10. doi: 10.1183/09031936.04.00120603.
5
Longitudinal changes in the nature, severity and frequency of COPD exacerbations.
Eur Respir J. 2003 Dec;22(6):931-6. doi: 10.1183/09031936.03.00038303.
8
Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2003 Apr 15;167(8):1090-5. doi: 10.1164/rccm.200210-1179OC. Epub 2003 Jan 24.
10
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.
Am J Respir Crit Care Med. 2003 Feb 15;167(4):544-9. doi: 10.1164/rccm.200206-583OC. Epub 2002 Nov 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验